{"product_id":"carotid-ultrasound-and-cardiovascular-risk-how-six-key-factors-work-together-like-a-spiders-web-to-predict-heart-disease","title":"Carotid Ultrasound and Cardiovascular Risk: How Six Key Factors Work Together Like a Spider's Web to Predict Heart Disease","description":"\u003cp\u003eCarotid ultrasonography (ultrasound imaging of the neck arteries) is a safe, non-invasive tool. Carotid ultrasonography can help predict a person's risk of cardiovascular disease (CVD, conditions affecting the heart and blood vessels). This comprehensive review examined six key aspects of carotid ultrasound and related risk factors. These aspects are the structure of the carotid artery walls, plaques (fatty deposits), inflammation, blood flow dynamics, early detection and intervention, and traditional cardiovascular risk factors. The authors found that carotid intima-media thickness (CIMT, the thickness of the artery wall's inner layers) and carotid plaques are well-established independent predictors of cardiovascular risk. However, inconsistent measurement methods and cut-off values across studies limit their clinical usefulness. The authors propose that these six factors work together like a \"SPIDER\" spinning the web of atherosclerosis (hardening and narrowing of the arteries). Combining carotid ultrasound results with other risk factors provides the most comprehensive assessment for guiding cardiovascular prevention decisions.\u003c\/p\u003e\n\n\u003ch1\u003eCarotid Ultrasound and Cardiovascular Risk: How Six Key Factors Work Together Like a Spider's Web to Predict Heart Disease\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n\u003cli\u003e\u003ca href=\"#background\"\u003eBackground: Why This Research Matters\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#methods\"\u003eHow the Research Was Conducted\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#cimt\"\u003eCarotid Intima-Media Thickness (CIMT)\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#diameters\"\u003eCarotid Artery Diameters\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#plaques\"\u003eCarotid Plaques\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#plaque-scores\"\u003ePlaque Scoring Systems\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#inflammation\"\u003eInflammation and Cardiovascular Risk\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#flow\"\u003eCarotid Blood Flow Dynamics\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#early-detection\"\u003eEarly Detection and Intervention\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#risk-factors\"\u003eTraditional Cardiovascular Risk Factors\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#clinical-implications\"\u003eClinical Implications for Patients\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#limitations\"\u003eLimitations of the Research\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations for Patients\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eCarotid ultrasonography is a safe, non-invasive, non-radioactive, and reproducible imaging method used to detect atherosclerosis in the neck arteries and screen high-risk patients.\u003c\/li\u003e\n\u003cli\u003eCIMT and carotid plaques are well-established independent predictors of cardiovascular risk, but inconsistent measurement methods and cut-off values across studies limit their clinical usefulness.\u003c\/li\u003e\n\u003cli\u003eThe presence of carotid plaques is a strong independent predictor of cardiovascular events, even in patients who have already had a heart attack or stroke.\u003c\/li\u003e\n\u003cli\u003eNo single carotid ultrasound parameter is sufficient to accurately predict cardiovascular risk in patients without symptoms; results should be combined with other factors.\u003c\/li\u003e\n\u003cli\u003eThe authors propose six factors—structure, plaques, inflammation, dynamics, early detection, and risk factors—work together like a spider's web to predict heart disease.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"background\"\u003eBackground: Why This Research Matters\u003c\/h2\u003e\n\n\u003cp\u003eCarotid ultrasonography (a non-invasive, non-radioactive, and reproducible imaging method) is used to detect atherosclerosis (hardening and narrowing of the arteries) in the carotid arteries. Carotid ultrasonography is also used to screen high-risk patients for cardiovascular disease (CVD). The carotid arteries are the major blood vessels in the neck that supply blood to the brain.\u003c\/p\u003e\n\n\u003cp\u003eDoctors often recommend measuring the carotid intima-media thickness (CIMT) in patients who have no symptoms but are at intermediate risk for cardiovascular disease. This measurement helps doctors further classify a patient's risk level. However, inconsistent cut-off values and inconsistent added predictive value used in cardiovascular risk prediction models limit how useful CIMT is in clinical practice.\u003c\/p\u003e\n\n\u003cp\u003eCarotid plaques (fatty deposits that build up inside the artery walls) are independently associated with an increased cardiovascular disease risk. Doctors recommend screening for carotid plaques in patients with diabetes as part of a cardiovascular risk evaluation. However, the current method used to detect carotid plaques does not comprehensively consider their morphological properties (their shape, texture, and other physical characteristics).\u003c\/p\u003e\n\n\u003cp\u003eFurthermore, evidence that early interventions for carotid atherosclerosis are beneficial is lacking. Despite the large body of research, no single parameter of carotid ultrasonography is sufficient for accurately predicting cardiovascular risk in patients without symptoms. This limitation restricts the clinical use of carotid ultrasonography as a primary preventive measure.\u003c\/p\u003e\n\n\u003cp\u003eA recent review focusing on the usefulness of carotid ultrasonography for risk classification of cerebral (brain) and cardiovascular disease suggests the need to consider various aspects of carotid ultrasound imaging. In addition to carotid ultrasonography itself, other atherosclerotic factors affect carotid atherosclerosis and cardiovascular events.\u003c\/p\u003e\n\n\u003cp\u003eThe authors of this review propose combining carotid ultrasound, clinical conditions, and laboratory tests to comprehensively evaluate a patient's future risk of cardiovascular disease. They summarize the research progress, predictive value, and limitations of carotid ultrasonography in determining the structure of the carotid intima and media, plaques, and carotid flow velocity. They also discuss other carotid atherosclerotic factors, including inflammation, early detection and intervention, and traditional cardiovascular risk factors.\u003c\/p\u003e\n\n\u003ch2 id=\"methods\"\u003eHow the Research Was Conducted\u003c\/h2\u003e\n\n\u003cp\u003eThis article is a literature review, which means the authors examined and summarized previously published research studies on carotid ultrasonography and cardiovascular risk prediction. The authors assessed six aspects of research progress and limitations:\u003c\/p\u003e\n\n\u003col\u003e\n\u003cli\u003eThe structures of the carotid intima and media (the inner layers of the artery wall)\u003c\/li\u003e\n\u003cli\u003ePlaques (fatty deposits in the artery walls)\u003c\/li\u003e\n\u003cli\u003eInflammation (the body's immune response that contributes to artery damage)\u003c\/li\u003e\n\u003cli\u003eDynamics of carotid blood flow (how blood moves through the carotid arteries)\u003c\/li\u003e\n\u003cli\u003eEarly detection and intervention (finding and treating problems early)\u003c\/li\u003e\n\u003cli\u003eRisk factors for cardiovascular disease\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThe authors reviewed large population-based prospective studies (studies that followed groups of people over time) that assessed the association between CIMT and cardiovascular risk. The authors also reviewed studies that assessed the association between carotid plaques and cardiovascular risk. They summarized the measurement methods, endpoints (health outcomes measured), and hazard ratios (a statistical measure of how much a factor increases risk) from these studies.\u003c\/p\u003e\n\n\u003ch2 id=\"cimt\"\u003eCarotid Intima-Media Thickness (CIMT)\u003c\/h2\u003e\n\n\u003cp\u003eAn abnormal increase in CIMT reflects the progression of carotid atherosclerosis, which ultrasound can detect clearly. CIMT has been suggested to be an independent predictor of the risk of new cardiovascular disease in most studies. Moreover, a slower CIMT progression caused by therapeutic intervention (treatment) could predict the degree of cardiovascular risk reduction.\u003c\/p\u003e\n\n\u003cp\u003eCIMT is measured between the lumen-intima and the media-adventitia interfaces at the far wall of the carotid arteries on ultrasound images. These images show an obvious \"double-line\" sign. Changes in the intima and media have been further specified: the intima layer is thicker and the medial layer is thinner in patients with cardiovascular disease than in healthy individuals.\u003c\/p\u003e\n\n\u003cp\u003eThere were relatively few small-scale cross-sectional studies (studies that look at a population at one point in time) calculating the age-specific normal value of CIMT in healthy individuals. However, the measurement methods and normative values of CIMT were not identical across these studies. To date, a stable normative value for cardiovascular disease risk prediction has not yet been defined.\u003c\/p\u003e\n\n\u003cp\u003eThe CIMT measurements, endpoint events, and cut-off values used in large population-based prospective studies vary considerably. The discrepancies between studies concern five aspects:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eThe sites of CIMT measurement\u003c\/li\u003e\n\u003cli\u003eThe CIMT parameters used for statistical analysis\u003c\/li\u003e\n\u003cli\u003eThe endpoints of each study\u003c\/li\u003e\n\u003cli\u003eWhether carotid plaques are included in the measurement\u003c\/li\u003e\n\u003cli\u003eThe cut-off values used for predicting cardiovascular disease risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eMost studies measured the CIMT at the far wall of bilateral (both sides) common carotid arteries (CCAs). However, some studies measured the CIMT at both the near and far walls, at the carotid bifurcations (BIFs, where the artery splits), and internal carotid arteries (ICAs). Some studies measured only the right common carotid artery. Measurements were recorded at three different angles or were repeated three times.\u003c\/p\u003e\n\n\u003cp\u003eDifferent studies used different CIMT parameters for establishing risk prediction models. These included the maximal CCA-IMT, the mean maximal CIMT, the mean CIMT normalized by the IMT of the bilateral CCAs, BIFs, and ICAs. These also included the mean CCA-IMT and ICA-IMT of the bilateral carotid arteries.\u003c\/p\u003e\n\n\u003cp\u003eFor example, Chambless et al. defined the mean CIMT as the average of the bilateral CCA-IMT, BIF-IMT, and ICA-IMT. Baldassarre et al. and O'Leary et al. reported different values for the mean CIMT of the bilateral CCAs and ICAs.\u003c\/p\u003e\n\n\u003cp\u003eGrowing evidence suggests that CIMT can predict cardiovascular disease risk partly because of the inclusion of plaques. Plaques might magnify the measurement of the intima-media thickness and elicit false positive associations with cardiovascular disease risk. Studies that reported the mean CCA-IMT excluding plaques did not identify an association between the CCA-IMT and risk of new cardiovascular disease.\u003c\/p\u003e\n\n\u003cp\u003eAnother source of heterogeneity (variation between studies) was the arbitrary cut-off value used to predict the risk of cardiovascular endpoints. For instance, the top quintile (top 20%) of the mean CCA-IMT was 1.18 mm in the Cardiovascular Health Study. The top quintile of the mean CCA-IMT was 0.805 mm in the Three-City Study. Such heterogeneity might affect the comparison and synthesis of CIMT results.\u003c\/p\u003e\n\n\u003cp\u003eThe consensus for the use of carotid ultrasound to evaluate cardiovascular disease risk and identify subclinical vascular disease was issued by the American Society of Echocardiography (ASE) in 2008. This consensus established a standard method for CIMT assessment, categorized into four parts:\u003c\/p\u003e\n\n\u003col\u003e\n\u003cli\u003eA cross-sectional scan for an overview of the arterial wall structure\u003c\/li\u003e\n\u003cli\u003eA Doppler ultrasound scan for identifying significant stenosis (narrowing)\u003c\/li\u003e\n\u003cli\u003eThree-angle scans (anterior, lateral, and posterior) for the identification and description of plaques at the near and far walls of bilateral CCAs, bulbs, and ICAs\u003c\/li\u003e\n\u003cli\u003eThree-angle images of the \"double line\" sign for CIMT measurements, with the distal 1 cm of each CCA gated by the optimized R-wave (a specific point in the heartbeat cycle)\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThe accuracy of far-wall CCA-IMT measurements has been validated by the absence of a significant difference from in vitro specimens (laboratory samples). However, near-wall measurements are less accurate due to liable artifacts (imaging distortions). Three-angle scans of the CCAs help prevent an irregular CIMT from being inadequately evaluated without considering the near-wall CIMT.\u003c\/p\u003e\n\n\u003cp\u003eFor example, the far-wall CIMT of a 50-year-old man was clearly measured to be 0.8 millimeters (mm). The CIMT of another 41-year-old man was significantly thicker, measuring 1.3 mm at the near wall. In addition to CCA-IMT, significantly thicker CIMT values at carotid bulbs and ICAs should not be neglected, especially in patients with normal CCA-IMT values, to avoid underestimations of cardiovascular risk.\u003c\/p\u003e\n\n\u003cp\u003eThe Mannheim CIMT and Plaque Consensus states that CIMT can be assessed at carotid bulbs and ICAs. A CIMT at or above the 75th percentile after adjusting for the patient's age, ethnicity, and sex is recommended as an indication of an increased cardiovascular disease risk.\u003c\/p\u003e\n\n\u003cp\u003eA comprehensive meta-analysis (a statistical analysis that combines results from multiple studies) of 16 prospective studies performed by the PROG-IMT collaboration revealed a positive association. The mean CCA-CIMT was associated with a 16% increase in cardiovascular risk. However, this analysis found no association between CIMT progression and cardiovascular events. Moreover, the identification of meaningful normative values is difficult due to the substantial heterogeneity in the percentiles of CIMT reported across studies.\u003c\/p\u003e\n\n\u003cp\u003eAnother meta-analysis challenged the additive value of CIMT. It showed only a 0.8% net reclassification improvement (NRI) after CIMT was added to the 10-year Framingham risk score (FRS)-based risk prediction model. The challenge to the predictive value of CIMT progression and the additive value of CIMT to the FRS reduces the priority to measure the CIMT in cardiovascular risk assessments.\u003c\/p\u003e\n\n\u003cp\u003eInterestingly, recent research using two cohorts with 20,862 participants from the ARIC study and the CHS study revealed a significantly positive association. CIMT was associated with sudden cardiac death (SCD) during at least 13.1 years of follow-up. The long-term predictive value of CIMT for sudden cardiac death may be better than the unsatisfactory predictive ability of 10-year total cardiovascular risk.\u003c\/p\u003e\n\n\u003cp\u003eIn short, far-wall CIMT is a useful independent predictor for cardiovascular disease risk, with good reproducibility and accuracy. Due to the heterogeneity of CIMT measurements, CIMT results must be combined with other atherosclerotic markers instead of using carotid ultrasound alone. Furthermore, the lifetime predictive value of the CIMT in young adults is worth exploring, regardless of whether the 10-year risk predictive value is low.\u003c\/p\u003e\n\n\u003ch2 id=\"diameters\"\u003eCarotid Artery Diameters\u003c\/h2\u003e\n\n\u003cp\u003eThe common carotid artery (CCA) diameter is affected by the CIMT and carotid plaques. The CCA diameter increases in individuals with carotid atherosclerosis and is measured transversely at a plaque-free site.\u003c\/p\u003e\n\n\u003cp\u003eAn increased carotid lumen diameter (the width of the open channel inside the artery) was demonstrated to be associated with increased all-cause mortality (death from any cause). However, its correlation with new cardiovascular disease was uncertain.\u003c\/p\u003e\n\n\u003cp\u003eThe interadventitia CCA diameter (ICCAD, the full width of the artery including its outer layers) is easier to detect than the lumen diameter. An increase in the ICCAD exhibits additive predictive value for composite cardiovascular events (combined heart-related events).\u003c\/p\u003e\n\n\u003cp\u003eA meta-analysis of four cohort studies also reported that patients with a CCA diameter greater than 8 mm had a higher risk of total cardiovascular disease. Patients with a diameter less than 7 mm had a lower risk of total cardiovascular disease. However, direct evidence that the ICCAD or the CCA diameter predicts the risk of coronary heart disease (heart artery disease) is unavailable.\u003c\/p\u003e\n\n\u003cp\u003eCarotid artery diameters represent the structural and functional changes induced by atherosclerosis and may be associated with an increased cardiovascular risk. Carotid arterial diameters should not be neglected in risk assessments.\u003c\/p\u003e\n\n\u003ch2 id=\"plaques\"\u003eCarotid Plaques\u003c\/h2\u003e\n\n\u003cp\u003eIn people aged 30 to 79 years, the global prevalence of an increased CIMT is estimated to be 27.6%. The global prevalence of the presence of carotid plaques is estimated to be 21.1% in 2020. The percent increase in both an increased CIMT and the presence of carotid plaques is more than 50% in 2020. The carotid atherosclerotic burden is significantly increased worldwide.\u003c\/p\u003e\n\n\u003cp\u003eAccumulating evidence from prospective studies has identified the presence of carotid plaques as a strong independent cardiovascular disease risk factor, with significant additive value for risk prediction models. Carotid plaques are defined as having a focal thickness that is at least 50% greater than that of the surrounding wall. Alternatively, a carotid plaque is a focal thickness distinct from the adjacent boundary greater than 1.5 mm, with protrusion into the lumen (the open channel of the artery). Plaques easily occur at carotid bulbs.\u003c\/p\u003e\n\n\u003cp\u003eCarotid plaques are classified into three grades according to the up-to-date recommendations for the assessment of carotid arterial plaque by ultrasound from the American Society of Echocardiography (ASE):\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGrade I:\u003c\/strong\u003e Protuberant plaques with CIMT less than 1.5 mm\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGrade II:\u003c\/strong\u003e Either protuberant or diffuse plaques with CIMT at or above 1.5 mm but less than 2.5 mm\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGrade III:\u003c\/strong\u003e Either protuberant or diffuse plaques with CIMT at or above 2.5 mm\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003ePlaques are recommended to be detected at both the near and far walls of bilateral CCA, carotid bulb, and ICA segments. The presence of carotid plaques after adjustment for the patient's age, sex, and ethnicity implicates an increased cardiovascular disease risk. Carotid atherosclerosis including carotid plaques is a strong cardiovascular predictor, even among patients with previous myocardial infarction (heart attack) or previous stroke.\u003c\/p\u003e\n\n\u003cp\u003eHeterogeneity in plaque measurements mainly exists due to heterogeneity in three aspects:\u003c\/p\u003e\n\n\u003col\u003e\n\u003cli\u003eThe site at which plaques are detected\u003c\/li\u003e\n\u003cli\u003eThe parameters of interest for plaques\u003c\/li\u003e\n\u003cli\u003eThe definition of plaques\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eMost of the studies detected plaques at bilateral CCAs, carotid bulbs, and ICAs. A few studies detected carotid plaques in the bilateral CCAs and bulbs, bilateral CCAs and ICAs, and only the right carotid arteries.\u003c\/p\u003e\n\n\u003cp\u003eThe parameters of interest for carotid plaques also varied across studies. Despite the presence of plaques, most studies chose plaque scores to predict risk. Some studies collected data on plaque echogenicity (how the plaque reflects sound waves), plaque texture, plaque surface, and plaque area. In addition, early studies defined plaques as a focal area with protrusion into the lumen without a cut-off standard for CIMT. This might lead to overestimations of the predictive value of CIMT.\u003c\/p\u003e\n\n\u003cp\u003eThe heterogeneity of plaque parameters also increased the difficulty of identifying a stable cut-off value for plaque number or properties to predict cardiovascular risk. Uniform quantification of carotid plaques may help to better establish the cut-off value for parameters of carotid plaques in cardiovascular risk prediction.\u003c\/p\u003e\n\n\u003ch2 id=\"plaque-scores\"\u003ePlaque Scoring Systems\u003c\/h2\u003e\n\n\u003cp\u003eVarious scoring systems with satisfactory predictive ability have been developed to quantitatively measure carotid plaques. In the Rotterdam study, the plaque score was computed as the total number of sites where plaques occurred in bilateral CCAs, BIFs, and ICAs, with a total score of 6 points.\u003c\/p\u003e\n\n\u003cp\u003eA similar score was calculated for the near and far walls of the bilateral CCAs, BIFs, and ICAs, with a total score of 12 points, in the MESA study. Plaque scores reflecting the severity of plaques in carotid arteries also showed a significant association with cardiovascular events.\u003c\/p\u003e\n\n\u003cp\u003eHanda et al. reported an algorithm that calculated the sum of the bilateral maximal thickness of each plaque in four segments, which was associated with the severity of coronary artery lesions. Prati et al. established a scoring system consisting of four parts: the degree of stenosis (narrowing), echogenicity (sound-reflection properties), heterogeneity of the texture, and the presence of calcification (calcium deposits).\u003c\/p\u003e\n\n\u003ch2 id=\"inflammation\"\u003eInflammation and Cardiovascular Risk\u003c\/h2\u003e\n\n\u003cp\u003eInflammatory diseases and biomarkers (measurable substances in the blood that indicate inflammation) should be evaluated for a full assessment of the inflammatory burden for atherosclerosis. Inflammation is the body's immune response, and chronic inflammation contributes to the buildup of plaques in the arteries.\u003c\/p\u003e\n\n\u003cp\u003eThe authors of this review emphasize that a complete evaluation of cardiovascular risk must go beyond imaging alone. Blood tests that measure inflammatory markers can provide additional information about a patient's risk level. This combined approach helps doctors understand the full picture of a patient's cardiovascular health.\u003c\/p\u003e\n\n\u003ch2 id=\"flow\"\u003eCarotid Blood Flow Dynamics\u003c\/h2\u003e\n\n\u003cp\u003eCarotid flow velocity (the speed at which blood moves through the carotid arteries) is not only an indicator for stenosis (narrowing of the artery) but also a potential risk predictor. When the carotid arteries narrow due to plaque buildup, blood flow velocity changes in measurable ways.\u003c\/p\u003e\n\n\u003cp\u003eDoctors use Doppler ultrasound to measure how fast blood flows through the carotid arteries. Higher flow velocities can indicate significant narrowing. However, the authors note that flow velocity may also provide information about cardiovascular risk beyond just detecting stenosis. This makes carotid flow velocity a potentially valuable additional measurement in comprehensive risk assessments.\u003c\/p\u003e\n\n\u003ch2 id=\"early-detection\"\u003eEarly Detection and Intervention\u003c\/h2\u003e\n\n\u003cp\u003eCarotid atherosclerosis should be detected and treated early. Additional clinical trials are needed to determine the efficacy of these measures in reducing cardiovascular disease risk.\u003c\/p\u003e\n\n\u003cp\u003eThe authors emphasize that identifying carotid atherosclerosis at an early stage creates an opportunity for intervention before serious cardiovascular events occur. However, they acknowledge that more research is needed to prove that early treatment of carotid atherosclerosis actually reduces the risk of heart attacks, strokes, and other cardiovascular events.\u003c\/p\u003e\n\n\u003cp\u003eCardiovascular risk factors tend to affect carotid plaques. Early treat-to-target therapy (treatment aimed at achieving specific target levels for risk factors) might yield clinical benefits. This approach means identifying and aggressively treating risk factors such as high blood pressure, high cholesterol, and diabetes before they cause irreversible damage to the arteries.\u003c\/p\u003e\n\n\u003ch2 id=\"risk-factors\"\u003eTraditional Cardiovascular Risk Factors\u003c\/h2\u003e\n\n\u003cp\u003eTraditional cardiovascular risk factors interact with carotid atherosclerosis in important ways. These risk factors include conditions and behaviors that increase a person's likelihood of developing cardiovascular disease.\u003c\/p\u003e\n\n\u003cp\u003eThe authors note that cardiovascular risk factors tend to affect carotid plaques specifically. This means that patients with risk factors such as high blood pressure, high cholesterol, smoking, diabetes, and obesity are more likely to develop carotid plaques. The presence of these risk factors should prompt doctors to evaluate the carotid arteries more carefully.\u003c\/p\u003e\n\n\u003cp\u003eThe review emphasizes that carotid ultrasound results should be combined with other atherosclerotic factors. A comprehensive risk assessment may help guide cardiovascular prevention decisions. This means that doctors should not rely on carotid ultrasound alone but should consider the full picture of a patient's risk factors, clinical condition, and laboratory test results.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical-implications\"\u003eClinical Implications for Patients\u003c\/h2\u003e\n\n\u003cp\u003eBased on the six aspects reviewed, the authors consider that these six important factors act like a \"SPIDER\" spinning the web of atherosclerosis. A timely comprehensive assessment and intervention may halt the progression to cardiovascular disease.\u003c\/p\u003e\n\n\u003cp\u003eFor patients, this means that carotid ultrasound is a valuable tool, but it works best when combined with other information. The six factors in the \"SPIDER\" model are:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eS\u003c\/strong\u003etructures of the carotid intima and media (CIMT and artery diameters)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eP\u003c\/strong\u003elaques (their presence, number, location, and characteristics)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eI\u003c\/strong\u003enflammation (inflammatory diseases and biomarkers)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eD\u003c\/strong\u003eynamics of carotid blood flow (flow velocity)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eE\u003c\/strong\u003early detection and intervention\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eR\u003c\/strong\u003eisk factors for cardiovascular disease\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe authors conclude that carotid ultrasound results should be combined with other atherosclerotic factors. A comprehensive risk assessment may help guide cardiovascular prevention decisions. This integrated approach is more powerful than any single measurement alone.\u003c\/p\u003e\n\n\u003cp\u003eFor patients with intermediate cardiovascular risk, carotid ultrasound can provide valuable additional information. The CIMT measurement, when performed correctly at the far wall of the common carotid artery, is a useful independent predictor of cardiovascular risk. Carotid plaques are an even stronger predictor, especially when their morphological properties are carefully evaluated.\u003c\/p\u003e\n\n\u003cp\u003ePatients should understand that the presence of carotid plaques indicates an increased risk of cardiovascular events, even in people who have already had a heart attack or stroke. This makes carotid ultrasound particularly valuable for secondary prevention (preventing future events in people who already have cardiovascular disease).\u003c\/p\u003e\n\n\u003ch2 id=\"limitations\"\u003eLimitations of the Research\u003c\/h2\u003e\n\n\u003cp\u003eThe authors identify several important limitations in the current research on carotid ultrasonography and cardiovascular risk prediction.\u003c\/p\u003e\n\n\u003cp\u003eFirst, there is substantial heterogeneity (variation) in how CIMT is measured across different studies. The sites of measurement, the parameters used for analysis, the endpoints studied, whether plaques are included, and the cut-off values used all differ between studies. This makes it difficult to compare results and establish universal standards.\u003c\/p\u003e\n\n\u003cp\u003eSecond, the additive value of CIMT to existing risk prediction models is limited. One meta-analysis showed only a 0.8% net reclassification improvement when CIMT was added to the Framingham risk score. This modest improvement challenges the priority of measuring CIMT in routine cardiovascular risk assessments.\u003c\/p\u003e\n\n\u003cp\u003eThird, the predictive value of CIMT progression over time is uncertain. The PROG-IMT collaboration found no association between CIMT progression and cardiovascular events, although it did find an association between the mean CCA-CIMT and a 16% increase in cardiovascular risk.\u003c\/p\u003e\n\n\u003cp\u003eFourth, there is no stable normative value for CIMT that can be universally applied. The percentiles of CIMT reported across studies vary substantially, making it difficult to define what constitutes an abnormal value.\u003c\/p\u003e\n\n\u003cp\u003eFifth, plaque measurements also suffer from heterogeneity. Different studies detect plaques at different sites, use different parameters of interest, and define plaques differently. This makes it difficult to establish stable cut-off values for plaque number or properties.\u003c\/p\u003e\n\n\u003cp\u003eSixth, direct evidence that early intervention for carotid atherosclerosis reduces cardiovascular events is lacking. While the authors recommend early detection and treatment, they acknowledge that additional clinical trials are needed to prove efficacy.\u003c\/p\u003e\n\n\u003cp\u003eFinally, direct evidence that the ICCAD or the CCA diameter predicts the risk of coronary heart disease is unavailable. While these measurements show promise, more research is needed to establish their predictive value.\u003c\/p\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations for Patients\u003c\/h2\u003e\n\n\u003cp\u003eBased on this comprehensive review, patients and their doctors should consider the following recommendations:\u003c\/p\u003e\n\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnderstand that carotid ultrasound is one part of a comprehensive assessment.\u003c\/strong\u003e No single measurement from carotid ultrasound is sufficient to accurately predict cardiovascular risk. The results should be combined with other clinical information and laboratory tests.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAsk about CIMT measurement if you are at intermediate cardiovascular risk.\u003c\/strong\u003e The CIMT at the far wall of the common carotid artery is a useful independent predictor of cardiovascular risk when measured correctly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTake carotid plaques seriously.\u003c\/strong\u003e The presence of carotid plaques is a strong independent predictor of cardiovascular events, even in patients who have already had a heart attack or stroke.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiscuss inflammatory markers with your doctor.\u003c\/strong\u003e Inflammatory diseases and biomarkers should be evaluated as part of a full assessment of cardiovascular risk.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConsider carotid flow velocity as part of your evaluation.\u003c\/strong\u003e Flow velocity is not only an indicator for stenosis but also a potential risk predictor.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdvocate for early detection and treatment.\u003c\/strong\u003e Carotid atherosclerosis should be detected and treated early, although more research is needed to confirm the benefits of early intervention.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManage traditional risk factors aggressively.\u003c\/strong\u003e Cardiovascular risk factors tend to affect carotid plaques. Early treat-to-target therapy might yield clinical benefits.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSeek a comprehensive risk assessment.\u003c\/strong\u003e A comprehensive cardiovascular assessment based on carotid ultrasonography combined with other atherosclerotic factors is important for risk classification and medical decisions.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThe authors conclude that these six important factors act like a \"SPIDER\" spinning the web of atherosclerosis. A timely comprehensive assessment and intervention may halt the progression to cardiovascular disease. Patients should work with their healthcare providers to ensure that all relevant factors are considered when evaluating their cardiovascular risk.\u003c\/p\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhat is carotid ultrasonography and why might my doctor recommend it?\u003c\/h3\u003e\n\u003cp\u003eCarotid ultrasonography is a safe, non-invasive, non-radioactive imaging method that detects hardening and narrowing of the neck arteries. Doctors use it to screen high-risk patients for cardiovascular disease and to measure the carotid intima-media thickness (CIMT) in people without symptoms who are at intermediate risk, helping to further classify their risk level.\u003c\/p\u003e\n\u003ch3\u003eWhat does an abnormal carotid intima-media thickness (CIMT) measurement mean?\u003c\/h3\u003e\n\u003cp\u003eAn abnormal increase in CIMT reflects progression of carotid atherosclerosis. CIMT has been suggested as an independent predictor of new cardiovascular disease in most studies. However, measurement methods and cut-off values vary widely across studies, so no stable normative value has been defined. A CIMT at or above the 75th percentile after adjusting for age, ethnicity, and sex is recommended as an indication of increased risk.\u003c\/p\u003e\n\u003ch3\u003eAre carotid plaques a serious finding?\u003c\/h3\u003e\n\u003cp\u003eYes. Accumulating evidence from prospective studies has identified the presence of carotid plaques as a strong independent cardiovascular disease risk factor, with significant additive value for risk prediction models. This increased risk applies even among patients who have already had a heart attack or stroke. Plaques are defined as focal thickness at least 50% greater than the surrounding wall, or greater than 1.5 mm with protrusion into the lumen.\u003c\/p\u003e\n\u003ch3\u003eHow is carotid ultrasound performed and is it safe?\u003c\/h3\u003e\n\u003cp\u003eCarotid ultrasonography is non-invasive, non-radioactive, and reproducible. A standard assessment includes a cross-sectional scan for an overview of the arterial wall, a Doppler scan to identify significant narrowing, three-angle scans of both carotid arteries to find plaques, and three-angle images of the double-line sign to measure CIMT at the far wall of each common carotid artery.\u003c\/p\u003e\n\u003ch3\u003eCan carotid ultrasound alone predict my risk of heart disease?\u003c\/h3\u003e\n\u003cp\u003eNo single parameter of carotid ultrasonography is sufficient for accurately predicting cardiovascular risk in patients without symptoms. The authors propose that six factors—artery wall structure, plaques, inflammation, blood flow dynamics, early detection and intervention, and traditional risk factors—work together like a spider spinning a web of atherosclerosis. Combining ultrasound results with other risk factors provides the most comprehensive assessment.\u003c\/p\u003e\n\u003ch3\u003eWhat other tests or information might my doctor combine with carotid ultrasound?\u003c\/h3\u003e\n\u003cp\u003eA complete evaluation should go beyond imaging alone. Blood tests measuring inflammatory markers can provide additional information about risk. Traditional risk factors such as high blood pressure, high cholesterol, smoking, diabetes, and obesity should be considered. Carotid flow velocity, measured by Doppler, may also provide information beyond detecting narrowing. Combining these with ultrasound gives a fuller picture.\u003c\/p\u003e\n\u003ch3\u003eDoes early treatment of carotid atherosclerosis prevent heart attacks or strokes?\u003c\/h3\u003e\n\u003cp\u003eThe authors emphasize that identifying carotid atherosclerosis early creates an opportunity for intervention before serious events occur. However, they acknowledge that direct evidence that early intervention reduces cardiovascular events is lacking, and additional clinical trials are needed to determine efficacy. Early treat-to-target therapy aimed at risk factors such as high blood pressure, high cholesterol, and diabetes might yield clinical benefits.\u003c\/p\u003e\n\u003ch3\u003eI was told my carotid ultrasound shows plaque and I'm at intermediate cardiovascular risk — when should I get a second opinion?\u003c\/h3\u003e\n\u003cp\u003eA second opinion is reasonable when a carotid ultrasound result will drive a prevention decision, because no single carotid measurement is sufficient to predict cardiovascular risk on its own. CIMT and plaque findings vary with measurement site, cut-off values, and whether plaques are included, and the added value of CIMT to risk scores is modest. Ask whether your result was combined with inflammatory markers, flow velocity, and traditional risk factors before treatment is set. Diagnostic Detectives Network provides independent expert second opinions.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eOriginal Article Title:\u003c\/strong\u003e China Predictive Value of Carotid Ultrasonography With Cardiovascular Risk Factors\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOI:\u003c\/strong\u003e \u003ca href=\"https:\/\/doi.org\/10.3389\/fcvm.2021.706490\" target=\"_blank\" rel=\"noopener\"\u003e10.3389\/fcvm.2021.706490\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eAuthors:\u003c\/strong\u003e Hongwei Li, Xiaolin Xu, Baoming Luo, and Yuling Zhang\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eAuthor Affiliations:\u003c\/strong\u003e Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology, Guangzhou, China; Department of Ultrasound, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eJournal:\u003c\/strong\u003e Frontiers in Cardiovascular Medicine\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003ePublication Details:\u003c\/strong\u003e Volume 8, Article 706490. Published August 10, 2021. DOI: 10.3389\/fcvm.2021.706490\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eArticle Type:\u003c\/strong\u003e Review Article\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eNote:\u003c\/strong\u003e This patient-friendly article is based on peer-reviewed research. The original article was a literature review that examined previously published studies on carotid ultrasonography and cardiovascular risk prediction. The authors reviewed large population-based prospective studies and summarized their findings on CIMT, carotid plaques, inflammation, blood flow dynamics, early detection and intervention, and traditional cardiovascular risk factors.\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47807293489308,"sku":null,"price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0599\/5449\/5644\/files\/ddn-medical-article-carotid-ultrasound-and-cardiovascular-risk-how-six-key-factors-work-together-like-a-spiders-web-to-predict-heart-disease-hero.png?v=1792041730","url":"https:\/\/diagnosticdetectives.com\/he\/products\/carotid-ultrasound-and-cardiovascular-risk-how-six-key-factors-work-together-like-a-spiders-web-to-predict-heart-disease","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}